Current Assets Alterar Data
AbbVie USD 25.58B 2.2B 2024-12
Amgen USD 29.03B 2.26B 2024-12
AstraZeneca USD 26.14B 312M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Galapagos EUR 3.47B 132.9M 2025-03
Genmab DKK 27.85B 4.16B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
Indivior 883M 44M 2025-03
J&J USD 71.55B 15.66B 2025-03
Merck USD 38.78B 1.58B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 745.13M 55.16M 2024-12
Perrigo USD 2.48B 1.23B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Prestige Brands USD 377.16M 3.54M 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
Sanofi 42.59B 12.51B 2024-12
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
UCB EUR 4.79B 1.47B 2024-12
Zoetis USD 5.99B 296M 2024-12



Sanofi Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.